Swiss National Bank’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.03M Hold
68,600
﹤0.01% 2127
2025
Q1
$1.11M Hold
68,600
﹤0.01% 2085
2024
Q4
$1.6M Buy
68,600
+19,000
+38% +$442K ﹤0.01% 1977
2024
Q3
$1.46M Buy
49,600
+13,500
+37% +$397K ﹤0.01% 2033
2024
Q2
$849K Sell
36,100
-3,000
-8% -$70.5K ﹤0.01% 2245
2024
Q1
$1.48M Buy
+39,100
New +$1.48M ﹤0.01% 2002